Cite

HARVARD Citation

    Katayama, S. et al. (2021). A CRISPR/Cas9‐based method for targeted DNA methylation enables cancer initiation in B lymphocytes. Advanced genetics. 2 (1), p. n/a. [Online]. 
  
Back to record